These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3313416)

  • 21. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
    Denolle T; Luo P; Guyene TT; Cazaubon C; Sissmann J; Corvol P; Ménard J
    Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
    Abe K; Ito T; Sato M; Haruyama T; Sato K; Omata K; Hiwatari M; Sakurai Y; Imai Y; Yoshinaga K
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():141s-144s. PubMed ID: 7004721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.
    Witzgall H; Hirsch F; Scherer B; Weber PC
    Clin Sci (Lond); 1982 Jun; 62(6):611-5. PubMed ID: 7044652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise.
    Pickering TG; Case DB; Sullivan PA; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1566-8. PubMed ID: 7041599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The interrelation of the hypotensive action of captopril and the activity of the renin-angiotensin system].
    Liusov VA; Bakhshaliev AB; Ibragimov MA; Gadzhiev RF
    Sov Med; 1988; (9):6-9. PubMed ID: 3062815
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.
    Silberbauer K; Stanek B; Templ H
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):87S-93S. PubMed ID: 6753910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the indicators of the renin-angiotensin-aldosterone system, kallikrein-kinin system and arterial blood pressure in elderly patients with essential hypertension treated with captopril].
    Khartrodt V; Brozovskiĭ KKh; Beuer E; Gurke R; Faulhaber H
    Kardiologiia; 1988 Dec; 28(12):54-6. PubMed ID: 3072445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of endogenous angiotensin II and prostaglandins in the antihypertensive mechanism of angiotensin converting enzyme inhibitor in hypertension.
    Omata K; Abe K; Tsunoda K; Yasujima M; Chiba S; Sato M; Kudo K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):569-74. PubMed ID: 3038419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandins, renin-angiotensin system, and hypertension.
    Nasjletti A; Baer PG
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():171-8. PubMed ID: 3159199
    [No Abstract]   [Full Text] [Related]  

  • 31. Implication of renal prostaglandins in pathogenesis of essential hypertension.
    Abe K; Tsunoda K; Yasujima M; Chiba S; Sato M; Omata K; Kudo K; Yoshinaga K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():461-3. PubMed ID: 2936142
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of propranolol and indomethacin on the depressor action of captopril in patients with essential hypertension.
    Seto S; Aoi W; Iwami K; Yamaguchi T; Ashizawa N; Kusano S; Baba K; Doi Y; Kuramochi M; Hashiba K
    Clin Exp Hypertens A; 1987; 9(2-3):623-7. PubMed ID: 3301085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in peripheral venous distensibility and blood pressure modifications in borderline hypertension: evidence against a primary role for the renin-angiotensin-aldosterone system.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    J Hypertens Suppl; 1989 Dec; 7(6):S80-1. PubMed ID: 2698951
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of inhibition of prostaglandin synthesis on sympathetic nervous system function in man.
    Güllner HG; Lake CR; Bartter FC; Kafka MS
    J Clin Endocrinol Metab; 1979 Oct; 49(4):552-6. PubMed ID: 225346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril.
    Noerr B
    Neonatal Netw; 1991 Feb; 9(5):69-71. PubMed ID: 1944096
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of prostaglandin inhibition on dihydralazine induced acute effects in patients with essential hypertension.
    Reimann IW; Ratge D; Wisser H; Frölich JC
    Clin Exp Pharmacol Physiol; 1985; 12(1):79-89. PubMed ID: 3891171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [[Effects of salizole on the antihypertensive activity of captopril. Comparison with indomethacin].
    Puccetti F; Franchi M; Landini F; Burresi A; Di Perri T
    Recenti Prog Med; 1987 Apr; 78(4):148-53. PubMed ID: 3306844
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypertension and prostanoids--the etiology and its implications for treatment].
    Abe K; Takeuchi K
    Nihon Rinsho; 1990 Jun; 48(6):1246-53. PubMed ID: 2200897
    [No Abstract]   [Full Text] [Related]  

  • 39. Attenuation of hypertension by conjugation estrogens.
    Elias AN; Meshkinpour H; Valenta LJ
    Nephron; 1982; 30(1):89-92. PubMed ID: 6283409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril and phaeochromocytoma.
    Israeli A; Gottehrer N; Gavish D; Melmed RN
    Lancet; 1985 Aug; 2(8449):278-9. PubMed ID: 2862453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.